⚖️Extension of Temporary Scheduling for Designer Benzodiazepines
The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines--clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated July 26, 2023, DEA temporarily placed these five substances in schedule I of the Controlled Substances Act. This temporary order will extend the temporary scheduling of five designer benzodiazepines for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these five specified controlled substances.
Learn More📄SEC's Proposed Rule 194 Impacts Security-Based Swap Dealers
The SEC is soliciting comments regarding the proposed collection of information under Rule of Practice 194, which governs applications for statutory disqualifications among security-based swap dealers. The notice outlines the required process and burden hours for compliance, reflecting on the anticipated low volume of applications and notices.
Learn More🏺NAGPRA Notice for University of California, Berkeley Repatriation
In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the University of California, Berkeley has completed an inventory of human remains and associated funerary objects and has determined that there is a cultural affiliation between the human remains and associated funerary objects and Indian Tribes or Native Hawaiian organizations in this notice.
Learn More📚Inquiry into Copyright Claims Board under the CASE Act
As required by the Copyright Alternative in Small-Claims Enforcement Act of 2020, the U.S. Copyright Office is initiating a study of the Copyright Claims Board. To inform the Office's study, the Office seeks comments on issues pertaining to the Copyright Claims Board, including its use and efficacy.
Learn More